Ultragenyx Pharmaceutical (RARE) Other financing activities: 2020-2024
Historic Other financing activities for Ultragenyx Pharmaceutical (RARE) over the last 3 years, with Sep 2024 value amounting to $7.0 million.
- Ultragenyx Pharmaceutical's Other financing activities was N/A to $7.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.9 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 25100.00% up from last year.
- Latest data reveals that Ultragenyx Pharmaceutical reported Other financing activities of $7.0 million as of Q3 2024, which was up 12,600.00% from -$56,000 recorded in Q2 2023.
- Ultragenyx Pharmaceutical's 5-year Other financing activities high stood at $7.0 million for Q3 2024, and its period low was -$147,000 during Q3 2022.
- In the last 3 years, Ultragenyx Pharmaceutical's Other financing activities had a median value of -$119,000 in 2022 and averaged $916,714.
- Per our database at Business Quant, Ultragenyx Pharmaceutical's Other financing activities slumped by 239.39% in 2021 and then soared by 119.58% in 2023.
- Ultragenyx Pharmaceutical's Other financing activities (Quarterly) stood at -$87,000 in 2020, then tumbled by 63.22% to -$142,000 in 2021, then climbed by 16.20% to -$119,000 in 2022, then surged by 61.64% to -$56,000 in 2023, then reached $7.0 million in 2024.
- Its Other financing activities was $7.0 million in Q3 2024, compared to -$56,000 in Q2 2023 and $28,000 in Q1 2023.